Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

A cross sectional study to assess the prevalence of non-alcoholic fatty liver disease among type 2 diabetes patients

Breadcrumb

  • Home
  • A cross sectional study to assess the prevalence of non-alcoholic fatty liver disease among type 2 diabetes patients

Marjorie Miraclin K * and Hemalatha B

Faculty of Allied health Sciences, Dr MGR Educational and Research Institute.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 20(01), 196–203.
Article DOI: 10.30574/wjbphs.2024.20.1.0685
DOI url: https://doi.org/10.30574/wjbphs.2024.20.1.0685

Received on 16 August 2024; revised on 30 September 2024; accepted on 03 October 2024

The objective of this study was to determine the prevalence and factors associated with NAFLD among type 2 diabetes patients ; using a cross sectional study design, a representative sample of T2 DM patients were recruited from A.C.S Medical College And Hospital in Chennai. A detailed medical history as well as laboratory investigation were done NAFLD was diagnosed using abdominal ultrasonography examination. the overall prevalence of NAFLD was 59.3% (89 people) out of 150 T2DM patients. these patients had developed Intermediate fibrosis. In a multivariable regression analysis the risk of NAFLD was significantly higher among male T2DM patients with no alteration in the liver enzymes such as AST and ALT levels. Overall results shows that the most affected age group is between 40-50 years and Individual with BMI range more than 25 (obese) had higher incidence of NAFLD. It was concluded that NAFLD is a common association of T2DM, increasing BMI, poor dietary control are significant factors associated with NAFLD among type 2 DM patients. Health education to improve dietary control and testing for NAFLD among diabetic patients especially those with abnormal BMI are recommended for early detection and prevention of NAFLD.

NAFLD; T2DM; Ultrasonography Abdomen; Fibrosis; Liver Enzymes; Age Factor; Obese; BMI; Poor Diet

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0685.pdf

Preview Article PDF

Marjorie Miraclin K and Hemalatha B. A cross sectional study to assess the prevalence of non-alcoholic fatty liver disease among type 2 diabetes patients. World Journal of Biology Pharmacy and Health Sciences, 2024, 20(01), 196–203. Article DOI: https://doi.org/10.30574/wjbphs.2024.20.1.0685

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution